Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K213603
    Device Name
    SIGNA Artist Evo
    Date Cleared
    2022-02-11

    (88 days)

    Product Code
    Regulation Number
    892.1000
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SIGNA™ Artist Evo system is a whole body magnetic resonance scanner designed to support high signal-to-noise ratio, and short scan times. It is indicated for use as a diagnostic imaging device to produce axial, sagittal. coronal and oblique images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and/ or functions of the entire body, including, but not limited to, head, neart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. Depending on the region of interest being imaged, contrast agents may be used.

    The images produced by the SIGNA™ Artist Evo system reflect the spatial distribution or molecular environment of nuclej exhibiting magnetic resonance. These images and/or spectra when interpreted by a trained physician vield information that may assist in diagnosis.

    Device Description

    The SIGNA™ Artist Evo system is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio, and short scan times. The system features a superconducting magnet. The data acquisition system accommodates up to 128 independent receive channels in various increments and multiple independent coil elements per channel during a single acquisition series. The system uses a combination of time varying magnetic fields (gradients) and RF transmissions to obtain information regarding the density and position of elements exhibiting magnetic resonance. The system can image in the sagittal, coronal, axial, oblique, and double oblique planes, using various pulse sequences and reconstruction algorithms.

    AI/ML Overview

    The provided text is a 510(k) summary for the SIGNA™ Artist Evo magnetic resonance diagnostic device. It details how the device is considered substantially equivalent to a predicate device (SIGNA™ Artist) rather than presenting a study for meeting specific acceptance criteria itself. The document focuses on non-clinical testing for safety and performance, and the claim of "acceptable diagnostic image performance" based on sample clinical images, but does not outline a formal study with acceptance criteria for a specific AI or image perception outcome.

    Therefore, I cannot fulfill all parts of your request as the provided text does not contain the acceptance criteria and the comprehensive study details you've asked for related to device performance in an AI context.

    However, based on the information provided, here's what can be extracted and inferred regarding the device's substantial equivalence claim:


    1. Table of Acceptance Criteria and Reported Device Performance

    As this is a 510(k) for a magnetic resonance diagnostic device (not an AI algorithm with specific performance metrics like sensitivity/specificity for a particular disease), the "acceptance criteria" are related to substantial equivalence to a predicate device in terms of safety, technological characteristics, and image quality.

    Acceptance Criteria (Inferred from 510(k) Process)Reported Device Performance (Summary)
    Safety and Performance Standards ComplianceCompliant with: AAMI/ANSI ES60601-1, IEC 60601-1-2, IEC 60601-2-33, AAMI/ANSI 62304, applicable NEMA MS standards for MRI, NEMA PS3 (DICOM), ISO 10993.
    Technological CharacteristicsSame 1.5T LCC magnets, no changes to RF transmit/receive subsystems. Introduces new IRMW gradient coil. Key performance specifications (magnet stability, spatial homogeneity, max gradient strength) unchanged from predicate. Same software version as predicate with minor hardware accommodation changes. No changes to pulse sequences, imaging protocols, image processing.
    Image QualitySample clinical images demonstrate acceptable diagnostic image performance, substantially equivalent to the predicate device. No new hazards, adverse effects, or safety/performance concerns significantly different from general MR imaging identified.
    Risk ManagementSubject to similar risk management activities as the predicate device (Risk Analysis, Requirements Reviews, Design Reviews, Unit/Module/Integration/Performance/Simulated Use Testing).
    Indications for UseIdentical to the predicate device.

    Regarding specific study details for AI/perception performance:

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • The document states: "Sample clinical images have been included in this submission." It does not specify a test set sample size, data provenance, or whether it was retrospective or prospective. This implies a qualitative assessment rather than a structured quantitative study.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Not specified. The assessment of "acceptable diagnostic image performance" would inherently involve expert interpretation, but the number and qualifications of these experts are not detailed.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Not specified.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • No MRMC comparative effectiveness study is described. The device is an MRI scanner, not an AI-assisted diagnostic tool discussed in this document.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not applicable as this is a medical imaging device, not an AI algorithm being evaluated for standalone performance. "The images produced...when interpreted by a trained physician yield information that may assist in diagnosis."

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • For the "acceptable diagnostic image performance," the ground truth is implicitly expert interpretation of images for diagnostic quality, likely a qualitative assessment. There's no mention of pathology or outcomes data being used to establish ground truth for this aspect.

    8. The sample size for the training set

    • Not applicable. There is no mention of a "training set" as this device is not an AI/machine learning algorithm undergoing a training/validation process in the context of this 510(k) summary.

    9. How the ground truth for the training set was established

    • Not applicable.

    In summary: The provided 510(k) relates to the substantial equivalence of an MRI scanner (SIGNA™ Artist Evo) to its predicate device (SIGNA™ Artist) based on non-clinical engineering and systems testing, and a qualitative assessment of sample clinical images for diagnostic performance. It is not a submission detailing the performance of an AI diagnostic algorithm, and therefore the specific criteria you've asked for related to AI-driven studies are not present in this document.

    Ask a Question

    Ask a specific question about this device

    K Number
    K202238
    Device Name
    SIGNA Artist
    Date Cleared
    2020-09-04

    (28 days)

    Product Code
    Regulation Number
    892.1000
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SIGNA Artist system is a whole body magnetic resonance scanner designed to support high signalto-noise ratio, and short scan times. It is indicated for use as a diagnostic imaging device to produce axial, sagittal, coronal. and oblique images, spectroscopic images, parametric maps, and/or spectra, dynamic images of the structures and/or functions of the entire body, including, but not limited to, head, neck, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body. Depending on the region of interest being imaged, contrast agents may be used.

    The images produced by the SIGNA Artist system reflect the spatial distribution or molecular environment of nuclei exhibiting magnetic resonance. These images and/or spectra when interpreted by a trained that may assist in diagnosis.

    Device Description

    The SIGNA Artist system is a whole body magnetic resonance scanner designed to support high resolution, high signal-to-noise ratio, and short scan times. The system features a superconducting magnet. The data acquisition system accommodates up to 128 independent receive channels in various increments and multiple independent coil elements per channel during a single acquisition series. The system uses a combination of time varying magnetic fields (gradients) and RF transmissions to obtain information regarding the density and position of elements exhibiting magnetic resonance. The system can image in the sagittal, coronal, axial, oblique, and double oblique planes, using various pulse sequences and reconstruction algorithms.
    This 510(k) submission is for the SIGNA Artist 1.5T MR system, and has been triggered by the addition of the AIR Recon DL software feature.
    The AIR Recon DL feature has been previously cleared for use on the SIGNA Premier 3T system through K193282, which is used as a reference device for this submission.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study that proves the device meets them, based on the provided text:

    Acceptance Criteria and Device Performance for GE Healthcare SIGNA Artist with AIR Recon DL

    The provided document describes the 510(k) submission for the GE Healthcare SIGNA Artist system with the added AIR Recon DL software feature. The study focuses on evaluating the impact of this new feature on image quality.

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria CategorySpecific CriteriaReported Device Performance
    Image QualitySNR (Signal-to-Noise Ratio) Improvement: Improved SNR with AIR Recon DL.Nonclinical and clinical testing demonstrated that AIR Recon DL improves SNR. Additionally,AIR Recon DL was able to maintain image SNR for images acquired with a reduced scan time.
    Sharpness Improvement: Improved image sharpness with AIR Recon DL.Nonclinical and clinical testing demonstrated that AIR Recon DL improves image sharpness. Additionally,AIR Recon DL did not sacrifice sharpness for images acquired with a reduced scan time.
    Low Contrast Detectability: Maintenance of low contrast detectability with AIR Recon DL.Nonclinical testing confirmed that AIR Recon DL maintains low contrast detectability.
    Noise Spectral Content Impact: Minimal impacts to noise spectral content with AIR Recon DL.Nonclinical testing confirmed that AIR Recon DL has minimal impacts to noise spectral content.
    Average Signal Intensity Bias: No significant bias introduced that might impact quantitative measurements based on signal intensity.Analysis was performed to confirm that the feature does not introduce significant bias that might impact quantitative measurements based on signal intensity.
    Motion Artifact Impact: Minimal impacts to the appearance of motion artifacts.Nonclinical testing confirmed that AIR Recon DL has minimal impacts to the appearance of motion artifacts.
    Clinical AcceptabilityEquivalent or Better Image Quality: Images produced with AIR Recon DL should have equivalent or better image quality compared to images without the feature as rated by radiologists.Radiologists were asked to rate images and comment on quality; the study showed that the AIR Recon DL feature provides images with equivalent or better image quality.
    Maintained Lesion Conspicuity: Lesion conspicuity should be maintained with AIR Recon DL.The study showed that lesion conspicuity is maintained.
    Radiologist Preference: Radiologists should prefer AIR Recon DL images for clinical use.The study showed that the radiologists preferred the AIR Recon DL images for clinical use.
    Scan TimeShorter Scan Times: Ability to enable shorter scan times while maintaining SNR and image sharpness.Nonclinical and clinical testing demonstrated that AIR Recon DL can enable shorter scan times while maintaining SNR and image sharpness.
    Safety and PerformanceNo New Hazards/Adverse Effects: The feature should not introduce any new hazards, adverse effects, or safety and performance concerns significantly different from those associated with MR imaging in general.The performance testing did not identify any new hazards, adverse effects, or safety and performance concerns that are significantly different from those associated with MR imaging in general.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the specific sample size for the test set used in the clinical evaluation. It mentions "sample images from clinically indicated scans."

    The data provenance for the clinical evaluation is implied to be retrospective as it involves "sample images from clinically indicated scans" that were then evaluated with and without the AIR Recon DL feature. The country of origin of the data is not specified.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    The document states that "Radiologists were asked to rate the images, and to comment on any notable aspects related to image quality." It does not specify the exact number of experts or their qualifications (e.g., years of experience, subspecialty).

    4. Adjudication Method for the Test Set

    The adjudication method is not explicitly stated. The text only mentions that "Radiologists were asked to rate the images, and to comment on any notable aspects related to image quality." This suggests an individual review process, but it doesn't detail how discrepancies or consensus building was handled if multiple radiologists reviewed the same case. It doesn't mention methods like 2+1, 3+1, or majority vote.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    A multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly stated as the primary methodology. The clinical evaluation described involves radiologists rating images "both with and without the AIR Recon DL feature" and stating their preference. While this provides comparative feedback, it does not quantify human reader improvement in terms of diagnostic accuracy or a specific effect size. The study concludes that radiologists "preferred the AIR Recon DL images for clinical use" and that lesion conspicuity was maintained, indicating a subjective improvement, but not a measurable effect size of diagnostic performance.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Yes, a standalone performance evaluation was done as part of the "Nonclinical Tests." These tests were designed to evaluate the AIR Recon DL feature "and its impact on image quality, including SNR, sharpness, low contrast detectability, and noise spectral content. Analysis was performed to confirm that the feature does not introduce significant bias that might impact quantitative measurements based on signal intensity. The influence of motion during image acquisition on the performance of AIR Recon DL was also evaluated." These are objective, quantitative measurements of the algorithm's output without human interpretation being the primary endpoint.

    7. The Type of Ground Truth Used

    For the nonclinical tests, the ground truth appears to be based on objective image quality metrics, physical phantoms, and simulated conditions. For instance, evaluating SNR, sharpness, noise spectral content, a lack of signal intensity bias, and motion artifact influence against established benchmarks or predefined ideal conditions.

    For the clinical tests, the ground truth for "equivalent or better image quality" and "maintained lesion conspicuity" was established by expert consensus/opinion from radiologists.

    8. The Sample Size for the Training Set

    The document does not specify the sample size for the training set used for the AIR Recon DL algorithm. It only mentions that the AIR Recon DL feature "has been previously cleared for use on the SIGNA Premier 3T system through K193282, which is used as a reference device for this submission." This implies the training was done prior to this specific submission for the SIGNA Artist.

    9. How the Ground Truth for the Training Set Was Established

    The document does not provide details on how the ground truth for the training set was established for the AIR Recon DL algorithm. While it mentions the algorithm was previously cleared for another device, it does not elaborate on the specific data used for its initial training and ground truth annotation.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1